Unusual side effect from a luteinizing hormone-releasing hormone agonist, leuprorelin, in the treatment of prostate cancer: a case report

Por Chang, John I-Chiang, Bucci, Joseph
Publicado no J Med Case Rep (2016)

Impact on genitourinary function and quality of life following focal irreversible electroporation of different prostate segments

Por Scheltema, Matthijs J., Chang, John I., van den Bos, Willemien, Gielchinsky, Ilan, Nguyen, Tuan V., de Reijke, Theo M., Siriwardana, Amila R., Böhm, Maret, de la Rosette, Jean J., Stricker, Phillip D.
Publicado no Diagn Interv Radiol (2018)

Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy

Por Scheltema, Matthijs J., Chang, John I., Böhm, Maret, van den Bos, Willemien, Blazevski, Alexandar, Gielchinsky, Ilan, Kalsbeek, Anton M. F., van Leeuwen, Pim J., Nguyen, Tuan V., de Reijke, Theo M., Siriwardana, Amila R., Thompson, James E., de la Rosette, Jean J., Stricker, Phillip D.
Publicado no World J Urol (2018)